USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity
Proceedings of the National Academy of Sciences · 30.07.2024 · 121 (31)
DOI: 10.1073/pnas.2403331121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 25.07.2024. Verfasst von Majid Pornour und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of Maryland, Baltimore, MD 21201. Hauptthemen laut MEDLINE: Disease Progression, Gene Expression Regulation, Neoplastic, Prostatic Neoplasms, Proto-Oncogene Proteins c-myc. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Cancer Institute (NCI), NCI NIH HHS, BLRD VA.
Abstract (Originalsprache)
Androgen receptor (AR) is a main driver for castration-resistant prostate cancer (CRPC). c-Myc is an oncogene underlying prostate tumorigenesis. Here, we find that the deubiquitinase USP11 targets both AR and c-Myc in prostate cancer (PCa). USP11 expression was up-regulated in metastatic PCa and CRPC. USP11 knockdown (KD) significantly inhibited PCa cell growth. Our RNA-seq studies revealed AR and c-Myc as the top transcription factors altered after USP11 KD. ChIP-seq analysis showed that either USP11 KD or replacement of endogenous USP11 with a catalytic-inactive USP11 mutant significantly decreased chromatin binding by AR and c-Myc. We find that USP11 employs two mechanisms to up-regulate AR and c-Myc levels: namely, deubiquitination of AR and c-Myc proteins to increase their stability and deubiquitination of H2A-K119Ub, a repressive histone mark, on promoters of AR and c-Myc genes to increase their transcription. AR and c-Myc reexpression in USP11-KD PCa cells partly rescued cell growth defects. Thus, our studies reveal a tumor-promoting role for USP11 in aggressive PCa through upregulation of AR and c-Myc activities and support USP11 as a potential target against PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of Maryland, Baltimore, MD 21201.
- Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD 21201.
- Department of Marine Biotechnology, Institute of Marine and Environmental Technology, University of Maryland, Baltimore, MD 21202.
- Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD 21201.
- Baltimore Veterans Affairs Medical Center, Baltimore, MD 21201.
- Department of Urology, University of Washington, Seattle, WA 98195.
ORCID-Profile: Majid Pornour, Hee-Young Jeon, Hyunju Ryu, Sudeep Khadka, Hegang Chen, Htoo Zarni Oo, Xuesen Dong, Jianfei Qi
Förderung
- HHS | NIH | National Cancer Institute (NCI)
- NCI NIH HHS
- BLRD VA
- NIGMS NIH HHS
- U.S. Department of Defense (DOD)
Zitieren
APA
Pornour, M., Jeon, H. Y., Ryu, H., Khadka, S., Xu, R., Chen, H., Hussain, A., Lam, H. M., Zhuang, Z., Oo, H. Z., Gleave, M., Dong, X., Wang, Q., Barbieri, C., & Qi, J. (2024). USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity. Proceedings of the National Academy of Sciences, 121(31). https://doi.org/10.1073/pnas.2403331121
Vancouver
Pornour M, Jeon HY, Ryu H, Khadka S, Xu R, Chen H, et al. USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity. Proceedings of the National Academy of Sciences. 2024;121(31). doi:10.1073/pnas.2403331121
BibTeX
@article{Pornour2024,
author = {Pornour, Majid and Jeon, Hee-Young and Ryu, Hyunju and Khadka, Sudeep and Xu, Rui and Chen, Hegang and Hussain, Arif and Lam, Hung-Ming and Zhuang, Zhihao and Oo, Htoo Zarni and Gleave, Martin and Dong, Xuesen and Wang, Qianben and Barbieri, Christopher and Qi, Jianfei},
title = {USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {31},
doi = {10.1073/pnas.2403331121}
}
EUVIMED